Literature DB >> 2909423

Pancreatic pseudocyst as a cause for secondary achalasia.

C A Woods1, P G Foutch, J P Waring, R A Sanowski.   

Abstract

Secondary achalasia is commonly due to cancer. Benign causes are rare and an association with pancreatitis has never been made. Our patient presented with clinical, manometric, endoscopic, and radiographic features of achalasia that occurred in conjunction with a pancreatic pseudocyst extending into the mediastinum. Documentation of this unique relationship was made on two occasions after episodes of complicated pancreatitis and was confirmed by restoration of normal esophageal function after drainage of the pseudocyst. Onset of dysphagia occurring in association with pancreatitis suggests the presence of a pseudocyst and secondary achalasia.

Entities:  

Mesh:

Year:  1989        PMID: 2909423     DOI: 10.1016/0016-5085(89)90786-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  4 in total

1.  Gallbladder function and gastric liquid emptying in achalasia.

Authors:  V Annese; N Caruso; L Accadia; A Gabbrielli; S Modoni; V Frusciante; T Federici
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

2.  Achalasia developing years after surgery for reflux disease: case reports, laparoscopic treatment, and review of achalasia syndromes following antireflux surgery.

Authors:  E C Poulin; N E Diamant; P Kortan; P A Seshadri; C M Schlachta; J Mamazza
Journal:  J Gastrointest Surg       Date:  2000 Nov-Dec       Impact factor: 3.452

Review 3.  The value of endoscopy and endosonography in the diagnosis of the dysphagic patient.

Authors:  R Lorenz; G Jorysz; M Classen
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

4.  Reversible achalasia-like motor pattern of esophageal body secondary to postoperative stricture of gastroesophageal junction.

Authors:  P Parrilla; J L Aguayo; L Martinez de Haro; A Ortiz; D A Martinez; G Morales
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.